Applications published 28 February 2007

Mixed co-crystals and pharmaceutical compsns comprising the same
Transform Pharmaceuticals 1755388*

Method for diminishing co-abuse potential
Celgene 1755393*

Cancer treatment method
SmithKline Beecham; Kumar, Rakesh 1755394*

AAV mediated gene delivery to cochlear cells
The University of Montana 1755400*

Dietary supplements containing extracts of cinnamon and methods of using the same to enhance creatine transport
Miller, Peter 1755401*

Compsns for inhalation therapy and methods of use
Phyzz 1753402*

Heat sterilisation of glucocorticosteroids
Norton Healthcare 1755554*

Dry powder compsns of glycopyrrolate
Vectura 1755555*

Directly compressible tricalcium phosphate
Rhodia 1755556*

Micropellet containing pellets and method of preparing such pellets
Glatt Air Techniques 1755557*

Dry powder pharmaceutical compsn, its preparation process and stable aqueous suspension obtained from such compsn
Eratech 1755558*

Bioavailable solid dosage forms of metaxalone
Spireas, Spiridon 1755559*

Pharmaceutical tablets having a relatively inactive segment
Accu-Break Pharmaceuticals 1755560*

Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihistamines
Wyeth 1755561*

Folic acid-containing contraceptive
Gruenenthal 1755562*

Pharmaceutical tablets comprising two or more unitary segments
Accu-Break Technologies 1755563*

Immediate release pharmaceutical tablets with height greater than width
Accu-Break Technologies 1755564*

Soft gelatin capsule comprising omega-3 polyunsaturated fatty acid
Tillotts Pharma 1755565*

Stable pharmaceutical formulations of benzimidazole compounds
Teva Pharmaceutical Industries 1755566*

Drug delivery product and methods
Nexmed Holdings 1755567*

Controlled release formulation for oral administration of metformin
Hanmi Pharm Co 1755568*

Wound dressing
Paul Hartmann 1755569*

Transdermal drug delivery device comprising extensor-relaxor means
Chowdhury, Dewan Fazlul Hoque 1755570*

Method for interfering with fibrosis
Merck Patent 1755571*

N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
Merck 1755572*

Pharmaceutical compsns comprising higher primary alcohols and ezetimibe and process of preparation thereof
Panacea Biotec 1755573*

PTEN inhibitors
Smeafore Pharmaceuticals 1755574*

Antifungal drug delivery
Nimni, Marcel 1755575*

Antimicrobial compsns and methods for their use
Dermacare-Vet Pty 1755576*

Novel use of peptide compounds for treating amyotrophic lateral sclerosis
Schwarz Pharma 1755577*

Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
Nycomed Pharma 1755578*

Method of treating or preventing pathologic effects of acute increases in hyperglycaemia and/or acute increases of free fatty acids
New York University; Albert Einstein School of Medicine of Yeshiva University 1755579*

Use of alpha-ketoglutarate and related compounds for lowering plasma lipids
SGP & Sons 1755580*

Methods and compsns for the treatment of myocardial conditions
Northern Sydney and Central Coast Area Health Service 1755582*

Pharmaceutical compsns for the prevention and treatment of atherosclerosis
Universite Rene Descartes 1755582*

Use of neboglamine (CR 2249) as an antipsychotic and neuroprotective
Rottapharm 1755583*

Treatment of myopia
The Regents of the University of California, Office of Technology Transfer 1755584*

Transthyretin Stabilisation
The Scripps Research Institute 1755585*

Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
The Regents of the University of California; Puerta, David; Cohen, Seth; Lewis, Jana 1755586*

Pharmaceutical compsns comprising higher primary alcohols and HMG CoA reductase inhibitor and process of preparation thereof
Panacea Biotec 1755587*

Compounds and compsns for treatment of cancer
Cancer Research Technology 1755588*

Methods of using and compsns comprising PDE4 modulators for the treatment and management of pulmonary hypertension
Celgene 1755589*

Combination of glycopyrrolate and beta2 adrenoceptor agonists
Novartis 1755590*

Ophthalmic formulations including selective alpha-1 antagonists
Ocularis Pharma 1755591*

Use of C-KIT inhibitors for treating inflammatory muscle disorders including myositis and muscular dystrophy
AB Science 1755592*

Naphthalene derivatives useful as histamine-3-receptor ligands
F Hoffmann-La Roche 1755593*

Combination therapy comprising an adenosine A1 receptor antagonist and an aldosterone inhibitor
Novacardia 1755594*

Use of roflumilast for the prophylaxis or treatment of emphysema
Altana Pharma 1755595*

Process for preparing atazanavir bisulphate and novel forms
Bristol-Myers Squibb 1755596*

Azaindoles modulating C-KIT activity and uses therefor
Plexxikon 1755597*

Methods of using and compsns comprising thalidomide for the treatment and management of pulmonary hypertension
Celgene 1755599*

Methods of using and compsns comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension
Celgene 1755600*

Inhibition of histone deacetylase
Miikana Therapeutics 1755601*

Monoamine neurotransmitter reuptake inhibitor for the inhibition of beta-amyloid (A beta 40 and A beta 32) generation
Neurosearch 1755602*

3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity
Merck 1755603*

Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
Alcasynn Pharmaceuticals 1755604*

Use of (4-alkylpiperzinyl)(phenyl)methanones in the treatment of Alzheimer's disease
Samaritan Pharmaceuticals; Georgetown University 1755605*

Quinazoline derivatives useful as vanilloid antagonists
Novartis 1755606*

Compounds and treatments for inhibiting kinase and/or HmG-CoA reductase
Pharmix 1755607*

Treatment with gemcitabine and an EGFR-inhibitor
F Hoffmann-La Roche 1755608*

Methods for treating and/or preventing aberrant proliferation of haematopoeitic cells
Icos 1755609*

Thienopyrimidines and thiazolopyrimidines for use in medicine
AstraZeneca 1755610*

Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
Pfizer 1755611*